Hollsteen
← Take-Two

Sales & marketing

Flow – sum over the period · $M

QuartersFiscal years

$MSales & marketing · Q1 FY2016: $46.0M · 10-Q 0001047469-15-006749 filed Aug 10, 2015Sales & marketing · Q2 FY2016: $55.0M · 10-Q 0001047469-15-008367 filed Nov 6, 2015Sales & marketing · Q3 FY2016: $60.0M · 10-Q 0001047469-16-010014 filed Feb 4, 2016Sales & marketing · Q4 FY2016: $38.0M · derived · 10-K 0001628280-17-005833 filed May 24, 2017Sales & marketing · Q1 FY2017: $71.0M · 10-Q 0001047469-16-014693 filed Aug 5, 2016Sales & marketing · Q2 FY2017: $80.0M · 10-Q 0001047469-16-016473 filed Nov 3, 2016Sales & marketing · Q3 FY2017: $96.0M · 10-Q 0001047469-17-000578 filed Feb 8, 2017Sales & marketing · Q4 FY2017: $38.0M · derived · 10-K 0001628280-18-006877 filed May 17, 2018Sales & marketing · Q1 FY2018: $52.0M · 10-Q 0001628280-17-007899 filed Aug 3, 2017Sales & marketing · Q2 FY2018: $77.0M · 10-Q 0001628280-17-011117 filed Nov 8, 2017Sales & marketing · Q3 FY2018: $80.0M · 10-Q 0001628280-18-001226 filed Feb 8, 2018Sales & marketing · Q4 FY2018: $47.0M · derived · 10-K 0001628280-19-006691 filed May 14, 2019Sales & marketing · Q1 FY2019: $58.0M · 10-Q 0001628280-18-010376 filed Aug 3, 2018Sales & marketing · Q2 FY2019: $94.0M · 10-Q 0001628280-18-013920 filed Nov 8, 2018Sales & marketing · Q3 FY2019: $161M · 10-Q 0001628280-19-001036 filed Feb 6, 2019Sales & marketing · Q4 FY2019: $78.0M · derived · 10-K 0001628280-20-008291 filed May 22, 2020Sales & marketing · Q1 FY2020: $92.0M · 10-Q 0001628280-19-010011 filed Aug 6, 2019Sales & marketing · Q2 FY2020: $150M · 10-Q 0001628280-19-013731 filed Nov 8, 2019Sales & marketing · Q3 FY2020: $137M · 10-Q 0001628280-20-001155 filed Feb 7, 2020Sales & marketing · Q4 FY2020: $80.0M · derived · 10-K 0001628280-21-010627 filed May 19, 2021Sales & marketing · Q1 FY2021: $85.0M · 10-Q 0001628280-20-011493 filed Aug 4, 2020Sales & marketing · Q2 FY2021: $114M · 10-Q 0001628280-20-015824 filed Nov 6, 2020Sales & marketing · Q3 FY2021: $140M · 10-Q 0001628280-21-001632 filed Feb 9, 2021Sales & marketing · Q4 FY2021: $107M · derived · 10-K 0001628280-22-014580 filed May 17, 2022Sales & marketing · Q1 FY2022: $104M · 10-Q 0001628280-22-021685 filed Aug 9, 2022Sales & marketing · Q2 FY2022: $136M · 10-Q 0001628280-21-021561 filed Nov 4, 2021Sales & marketing · Q3 FY2022: $135M · 10-Q 0001628280-23-002448 filed Feb 7, 2023Sales & marketing · Q4 FY2022: $141M · derived · 10-K 0001628280-23-019851 filed May 26, 2023Sales & marketing · Q1 FY2023: $272M · 10-Q 0001628280-22-021685 filed Aug 9, 2022Sales & marketing · Q2 FY2023: $444M · 10-Q 0001628280-22-028716 filed Nov 8, 2022Sales & marketing · Q3 FY2023: $447M · 10-Q 0001628280-23-002448 filed Feb 7, 2023Sales & marketing · Q4 FY2023: $423M · derived · 10-K 0001628280-24-024623 filed May 22, 2024Sales & marketing · Q1 FY2024: $399M · 10-Q 0001628280-24-036273 filed Aug 9, 2024Sales & marketing · Q2 FY2024: $335M · 10-Q 0001628280-23-037956 filed Nov 9, 2023Sales & marketing · Q3 FY2024: $367M · 10-Q 0001628280-25-004308 filed Feb 7, 2025Sales & marketing · Q4 FY2024: $449M · derived · 10-K 0001628280-25-026694 filed May 20, 2025Sales & marketing · Q1 FY2025: $431M · 10-Q 0001628280-24-036273 filed Aug 9, 2024Sales & marketing · Q2 FY2025: $461M · 10-Q 0001628280-24-045867 filed Nov 7, 2024Sales & marketing · Q3 FY2025: $389M · 10-Q 0001628280-25-004308 filed Feb 7, 2025Sales & marketing · Q4 FY2025: $402M · derived · 10-K 0001628280-26-037434 filed May 22, 2026Sales & marketing · Q1 FY2026: $409M · 10-Q 0001628280-26-054870 filed Aug 7, 2026Sales & marketing · Q2 FY2026: $537M · 10-Q 0001628280-25-050326 filed Nov 7, 2025Sales & marketing · Q3 FY2026: $433M · 10-Q 0001628280-26-005119 filed Feb 4, 2026Sales & marketing · Q4 FY2026: $392M · derived · 10-K 0001628280-26-037434 filed May 22, 2026Sales & marketing · Q1 FY2027: $370M · 10-Q 0001628280-26-054870 filed Aug 7, 202678a37046537Q1 FY2016Q1 FY2027Q4 FY2019
$MSales & marketing · Q4 FY2018: $47.0M · derived · 10-K 0001628280-19-006691 filed May 14, 2019Sales & marketing · Q1 FY2019: $58.0M · 10-Q 0001628280-18-010376 filed Aug 3, 2018Sales & marketing · Q2 FY2019: $94.0M · 10-Q 0001628280-18-013920 filed Nov 8, 2018Sales & marketing · Q3 FY2019: $161M · 10-Q 0001628280-19-001036 filed Feb 6, 2019Sales & marketing · Q4 FY2019: $78.0M · derived · 10-K 0001628280-20-008291 filed May 22, 2020Sales & marketing · Q1 FY2020: $92.0M · 10-Q 0001628280-19-010011 filed Aug 6, 2019Sales & marketing · Q2 FY2020: $150M · 10-Q 0001628280-19-013731 filed Nov 8, 2019Sales & marketing · Q3 FY2020: $137M · 10-Q 0001628280-20-001155 filed Feb 7, 202078a13747a161Q4 FY2018Q3 FY2020Q4 FY2019
Q4 FY2019
78a$M
derived
All values (45)
PeriodValue ($M)Status
Q1 FY2027370reported
Q4 FY2026392derived
Q3 FY2026433reported
Q2 FY2026537reported
Q1 FY2026409reported
Q4 FY2025402derived
Q3 FY2025389reported
Q2 FY2025461reported
Q1 FY2025431reported
Q4 FY2024449derived
Q3 FY2024367reported
Q2 FY2024335reported
Q1 FY2024399reported
Q4 FY2023423derived
Q3 FY2023447reported
Q2 FY2023444reported
Q1 FY2023272reported
Q4 FY2022141derived
Q3 FY2022135reported
Q2 FY2022136reported
Q1 FY2022104reported
Q4 FY2021107derived
Q3 FY2021140reported
Q2 FY2021114reported
Q1 FY202185reported
Q4 FY202080derived
Q3 FY2020137reported
Q2 FY2020150reported
Q1 FY202092reported
Q4 FY201978derived
Q3 FY2019161reported
Q2 FY201994reported
Q1 FY201958reported
Q4 FY201847derived
Q3 FY201880reported
Q2 FY201877reported
Q1 FY201852reported
Q4 FY201738derived
Q3 FY201796reported
Q2 FY201780reported
Q1 FY201771reported
Q4 FY201638derived
Q3 FY201660reported
Q2 FY201655reported
Q1 FY201646reported

CSV with all sources · Technical ID: sm

More metrics for Take-Two

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$78.0M (derived)
Period
Q4 FY2019, ended Mar 31, 2019 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 391M − 314M = $78.0M (FY value from 10-K 0001628280-20-008291; 9-month value from the Q3-10-Q)
Source
10-K, filed May 22, 2020 · 0001628280-20-008291
Location
us-gaap:SellingAndMarketingExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$78.0MMay 22, 202010-K 0001628280-20-008291derived · confidence 1. · current